Presentation is loading. Please wait.

Presentation is loading. Please wait.

Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation:

Similar presentations


Presentation on theme: "Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation:"— Presentation transcript:

1 Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT  Jennifer Heimall, Rebecca H. Buckley, Jennifer Puck, Thomas A. Fleisher, Andrew R. Gennery, Elie Haddad, Benedicte Neven, Mary Slatter, Skinner Roderick, K. Scott Baker, Andrew C. Dietz, Christine Duncan, Linda M. Griffith, Luigi Notarangelo, Michael A. Pulsipher, Morton J. Cowan  Biology of Blood and Marrow Transplantation  Volume 23, Issue 8, Pages (August 2017) DOI: /j.bbmt Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Patient summary/care transition document template.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation:"

Similar presentations


Ads by Google